文献速递胸部CT

计算机辅助诊断工具对CT肺结节风险分层的临床影响与泛化性

Clinical Impact and Generalizability of a Computer-Assisted Diagnostic Tool to Risk-Stratify Lung Nodules With CT.
PubMed 文献 · J Am Coll Radiol · 2022-09-03

该研究基于NLST数据开发机器学习分类器(mSI),在筛查与非筛查队列中评估其与Lung-RADS联用的效能。mSI的AUC为0.89,与现有临床模型相当,与Lung-RADS联用可显著提高敏感度(25%-117%)和筛查队列特异度(17%-33%),并可能使42%的NLST恶性结节提前诊断。

要点

  • mSI与Lung-RADS联用可提高肺结节恶性风险分层准确性。
  • 联用可显著提高敏感度,筛查队列特异度也提高。
  • 联用可能提前诊断并减少随访,需外部验证。

核心结论

  • 计算机辅助诊断软件mSI可改善筛查和偶然发现肺结节的风险分类,优于单独使用Lung-RADS。
  • mSI提供独立于现有影像和临床变量的预测价值,具有泛化性和临床实施潜力。

研究设计与样本

  • 研究为诊断准确性研究,开发并训练机器学习分类器mSI,使用NLST影像数据。
  • 外部验证队列包括三级转诊肺癌筛查项目数据集和外部非筛查CT数据集。
  • 共分析963名受试者、1331个结节,比较mSI联合Lung-RADS与单独Lung-RADS及Mayo和Brock风险计算器。

诊断标准与关键数值

  • mSI的AUC为0.89,现有临床风险模型AUC为0.86-0.88。
  • 与Lung-RADS相比,mSI在所有队列中显著提高敏感度25%-117%,筛查队列特异度显著提高17%-33%。
  • mSI与Lung-RADS联用可使42%的NLST恶性结节在既往年度CT扫描上获得早期诊断。

临床应用与阅片要点

  • 在日常阅片中,可将mSI与Lung-RADS联用以提高肺结节风险分层准确性。
  • 联用可能减少不必要的随访,并可能提前诊断恶性结节。
  • 需注意mSI基于NLST数据开发,外部应用时需验证其泛化性。

局限性

  • 研究为回顾性分析,可能存在选择偏倚。
  • 外部验证队列样本量及中心数未详细报告。
  • mSI需进一步在前瞻性研究中验证临床效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate whether an imaging classifier for radiology practice can improve lung nodule classification and follow-up.

METHODS: A machine learning classifier was developed and trained using imaging data from the National Lung Screening Trial (NSLT) to produce a malignancy risk score (malignancy Similarity Index [mSI]) for individual lung nodules. In addition to NLST cohorts, external cohorts were developed from a tertiary referral lung cancer screening program data set and an external nonscreening data set of all nodules detected on CT. Performance of the mSI combined with Lung-RADS was compared with Lung-RADS alone and the Mayo and Brock risk calculators.

RESULTS: We analyzed 963 subjects and 1,331 nodules across these cohorts. The mSI was comparable in accuracy (area under the curve = 0.89) to existing clinical risk models (area under the curve = 0.86-0.88) and independently predictive in the NLST cohort of 704 nodules. When compared with Lung-RADS, the mSI significantly increased sensitivity across all cohorts (25%-117%), with significant increases in specificity in the screening cohorts (17%-33%). When used in conjunction with Lung-RADS, use of mSI would result in earlier diagnoses and reduced follow-up across cohorts, including the potential for early diagnosis in 42% of malignant NLST nodules from prior-year CT scans.

CONCLUSION: A computer-assisted diagnosis software improved risk classification from chest CTs of screening and incidentally detected lung nodules compared with Lung-RADS. mSI added predictive value independent of existing radiological and clinical variables. These results suggest the generalizability and potential clinical impact of a tool that is straightforward to implement in practice.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Adams, Madtes, Burbridge, et al. Clinical Impact and Generalizability of a Computer-Assisted Diagnostic Tool to Risk-Stratify Lung Nodules With CT. J Am Coll Radiol. 2022. PMID: 36064040. doi:10.1016/j.jacr.2022.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。